Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07304271
Recruiting
Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis
Phase 3 · Italy, Netherlands, Sweden · 7 sites
Registry update: 7 Jul 2026
NCT06888193
Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Phase 1 · Canada, Switzerland, Germany, Spain, United States · 14 sites
Registry update: 18 Sept 2026
NCT07223424
Recruiting
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Phase 2 · United States · 1 site
Registry update: 16 Apr 2026
NCT07203378
Recruiting
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
Phase 2 · United States · 1 site
Registry update: 20 Aug 2026
NCT06735560
Recruiting
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
Phase 1/2 · France · 2 sites
Registry update: 13 May 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT07121413
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
Phase 2 · China · 12 sites
Registry update: 11 Feb 2026
NCT07369856
Recruiting
Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure
Not applicable · Canada · 1 site
Registry update: 27 Mar 2026
NCT07544784
Recruiting
AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)
Phase 2 · China · 1 site
Registry update: 22 Apr 2026
NCT06945120
Recruiting
ACT Lung Health Intervention: Phase Two
Not applicable · United States · 2 sites
Registry update: 13 Mar 2026
NCT06919562
Recruiting
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
Not applicable · Netherlands · 1 site
Registry update: 18 May 2026
NCT07245368
Recruiting
Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Phase 1/2 · Australia, New Zealand · 8 sites
Registry update: 6 Aug 2026
NCT07461805
Recruiting
Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features
Not applicable · Spain · 1 site
Registry update: 10 Mar 2026
NCT06954610
Recruiting
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Not applicable · Switzerland · 1 site
Registry update: 20 Nov 2025
NCT07291947
Recruiting
PULSAR Combined With Immunotherapy and Chemotherapy
Phase 1/2 · China · 1 site
Registry update: 18 Dec 2025
NCT07226609
Recruiting
A Dietary Study for People With Multiple Myeloma
Not applicable · United States · 7 sites
Registry update: 5 May 2026
NCT07225114
Recruiting
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Phase 2 · United States · 1 site
Registry update: 8 Jun 2026
NCT07220720
Recruiting
POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 · United States · 1 site
Registry update: 13 Apr 2026
NCT07216105
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Phase 1 · United States · 5 sites
Registry update: 2 Sept 2026
NCT07315854
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Phase 2 · China · 1 site
Registry update: 6 Jan 2026
NCT07107971
Recruiting
Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
Not applicable · Netherlands · 1 site
Registry update: 15 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.